JB/CALL/MERCK & CO./110/0.0333/21.03.25 Share Price

Warrant

MRKZJB

CH1303723204

Real-time Bid/Ask 13:30:27 04/06/2024 BST
0.71 CHF / 0.72 CHF -0.69% Intraday chart for JB/CALL/MERCK & CO./110/0.0333/21.03.25
Current month+5.88%
3 months-1.37%
Date Price Change
03/06/24 0.72 +5.88%
30/05/24 0.68 +1.49%
29/05/24 0.67 -2.90%
28/05/24 0.69 -10.39%
27/05/24 0.77 -3.75%

Delayed Quote Swiss Exchange

Last update June 03, 2024 at 04:20 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Bank Julius Bär
MRKZJB
ISINCH1303723204
Date issued 23/11/2023
Strike 110 $
Maturity 21/03/2025 (290 Days)
Parity 30 : 1
Emission price 0.24 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 0.83 CHF
Lowest since issue 0.22 CHF
Spread 0.01 CHF
Spread %1.39%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
128.4 USD
Average target price
142.2 USD
Spread / Average Target
+10.73%
Consensus
  1. Stock Market
  2. Warrants
  3. MRKZJB Warrant
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW